Agios Pharmaceuticals | Liquidités



Cash And Equivalent Changement Date
AbbVie USD 5.52B 1.73B 2024-12
Agios Pharmaceuticals USD 76.25M 177.48M 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Amgen USD 11.97B 2.96B 2024-12
Arrowhead Research USD 51.79M 47.4M 2024-12
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Bayer EUR 6.19B 1.57B 2024-12
Biogen USD 2.38B 675.8M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Daiichi Sankyo JPY 639.84B 42.31B 2025-03
Eli Lilly USD 3.27B 100.6M 2024-12
Exelixis USD 217.37M 40.97M 2025-01
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
Merck USD 13.24B 1.35B 2024-12
Moderna USD 1.93B 283M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Novartis USD 11.46B 2.15B 2024-12
Pfizer USD 1.04B 49M 2024-12
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Agios Pharmaceuticals Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.